Granisetron Terminated Phase 1 Trials for Vomiting / Nausea / Breast Cancer Supportive Care

IndicationsStatusPurposePhase
TerminatedSupportive Care1
clinicaltrials.gov IdentifierTitleDrugs
NCT01649258Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy